Family Medicine CME

Credits: 0.50 CME
Penn State College of Medicine
An Update on SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes
John B. Buse, MD, PhD
13 June, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Overcoming Challenges in the Management of Refractory Rheumatoid Arthritis: Expert Insight on the Clinical Potential of Novel Therapeutic Options
John Tesser, MD, FACP, FACR
29 April, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Realizing Your Patient's Potential: Embracing the Guidelines to Appropriately Individualize Care for Patients With Type 2 Diabetes
John Anderson, MD
17 April, 2019
Credits: 0.75 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Advances in the Management of Allergic and Inflammatory Diseases: Highlights From Washington, DC and San Francisco
Jonathan Corren, MD / Paul Yamauchi, MD
12 April, 2019
Credits: 0.75 CME
Medical Learning Institute, Inc.
Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?
Marwan Sabbagh, MD, FAAN
30 January, 2019
Credits: 0.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Systemic Juvenile Idiopathic Arthritis: A Closer Look at the Burden on Patients and Caregivers From Diagnosis to Treatment
Randy Cron, MD, PhD
27 December, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How Low Do We Go?
Marc Sabatine, MD, MPH
17 December, 2018
Credits: 1.25 CME
Medical Learning Institute, Inc.
Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?
Stewart Tepper, MD, FAHS
3 December, 2018
Credits: 1.00 CME
Penn State College of Medicine
Improving the Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention: How Is the Role of the Primary Care Clinician Evolving?
Deborah Friedman, MD, MPH
23 November, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies
Jonathan Corren, MD
7 November, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes for Patients With Refractory Rheumatoid Arthritis: The Role of JAK Inhibitors
William Rigby, MD
9 October, 2018
Credits: 0.50 MOC / CME / CPE
Medical Learning Institute, Inc.
Overcoming Barriers to Optimal Diagnosis and Treatment of Invasive Fungal Infections: Practical Guidance for the Hospital-Based Healthcare Provider
Thomas Patterson, MD, FACP, FIDSA
4 September, 2018
Credits: 0.50 CME
Penn State College of Medicine
Overcoming Disparities in the Accurate Diagnosis and Optimal Management of MDD in Rural America
J. Manning, MD
22 August, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances
Kevin Flaherty, MD, MS
13 August, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies
Nick Kim, MD
31 July, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Exploring the Latest Data in the Treatment of Uncontrolled Persistent Asthma: Clinical Highlights From San Diego
Nicola Hanania, MD, MS
13 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Advent of Immunotherapy in Gastrointestinal Cancers: MasterClass and Practicum on Checkpoint Inhibition and Biomarkers in Colorectal and Gastric Tumors
Prof Eric Van Cutsem, MD, PhD
3 July, 2018
Credits: 0.50 CME
Purdue University
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Considerations
Silvio Inzucchi, MD
29 June, 2018